Sight Sciences wins FDA 510(k) clearance for OMNI Ultra glaucoma system

PUBT · 1d ago
Sight Sciences wins FDA 510(k) clearance for OMNI Ultra glaucoma system
  • Sight Sciences won FDA 510(k) clearance for OMNI Ultra, a minimally invasive glaucoma surgery system for canaloplasty followed by trabeculotomy in adult POAG.
  • U.S. commercial launch targeted for Q4 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sight Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608041737PRIMZONEFULLFEED9803800) on August 04, 2026, and is solely responsible for the information contained therein.